EUR 102.1
(0.79%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.44 Billion EUR | 3.3% |
2022 | 1.4 Billion EUR | 16.64% |
2021 | 1.2 Billion EUR | 1.38% |
2020 | 1.18 Billion EUR | 6.01% |
2019 | 1.11 Billion EUR | 16.04% |
2018 | 963.3 Million EUR | 6.45% |
2017 | 904.9 Million EUR | 9.53% |
2016 | 826.2 Million EUR | 3.56% |
2015 | 797.8 Million EUR | 22.7% |
2014 | 650.2 Million EUR | 12.05% |
2013 | 580.3 Million EUR | 4.79% |
2012 | 553.8 Million EUR | 9.99% |
2011 | 503.5 Million EUR | 5.31% |
2010 | 478.1 Million EUR | 4.87% |
2009 | 455.9 Million EUR | 12.26% |
2008 | 406.1 Million EUR | 1.83% |
2007 | 398.8 Million EUR | 1.61% |
2006 | 392.5 Million EUR | 2.86% |
2005 | 381.6 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 777 Million EUR | 0.0% |
2023 Q2 | 728.6 Million EUR | 0.0% |
2023 FY | 1.44 Billion EUR | 3.3% |
2023 Q4 | 752 Million EUR | 0.0% |
2022 Q4 | 753.7 Million EUR | 0.0% |
2022 Q2 | 647.6 Million EUR | 0.0% |
2022 FY | 1.4 Billion EUR | 16.64% |
2021 FY | 1.2 Billion EUR | 1.38% |
2021 Q4 | 646.2 Million EUR | 0.0% |
2021 Q2 | 561.1 Million EUR | 0.0% |
2020 Q2 | 582.7 Million EUR | 0.0% |
2020 Q4 | 602.3 Million EUR | 0.0% |
2020 FY | 1.18 Billion EUR | 6.01% |
2019 Q2 | 528.5 Million EUR | 0.0% |
2019 FY | 1.11 Billion EUR | 16.04% |
2019 Q4 | 589.3 Million EUR | 0.0% |
2018 Q2 | 459.19 Million EUR | 0.0% |
2018 FY | 963.3 Million EUR | 6.45% |
2018 Q4 | 504.1 Million EUR | 0.0% |
2017 Q2 | 447.1 Million EUR | 0.0% |
2017 FY | 904.9 Million EUR | 9.53% |
2017 Q4 | 457.79 Million EUR | 0.0% |
2016 Q4 | 448.09 Million EUR | 0.0% |
2016 Q2 | 378.09 Million EUR | 0.0% |
2016 FY | 826.2 Million EUR | 3.56% |
2015 FY | 797.8 Million EUR | 22.7% |
2015 Q4 | 423.3 Million EUR | 0.0% |
2015 Q2 | 374.5 Million EUR | 0.0% |
2014 Q2 | 305.5 Million EUR | 0.0% |
2014 FY | 650.2 Million EUR | 12.05% |
2014 Q4 | 344.7 Million EUR | 0.0% |
2013 Q4 | 302.7 Million EUR | 0.0% |
2013 Q2 | 277.6 Million EUR | 0.0% |
2013 FY | 580.3 Million EUR | 4.79% |
2012 Q1 | -138.45 Million EUR | 0.0% |
2012 Q3 | -138.45 Million EUR | 0.0% |
2012 Q2 | - EUR | 100.0% |
2012 Q4 | - EUR | 100.0% |
2012 FY | 553.8 Million EUR | 9.99% |
2011 Q1 | -125.87 Million EUR | 0.0% |
2011 Q4 | - EUR | 100.0% |
2011 FY | 503.5 Million EUR | 5.31% |
2011 Q3 | -125.87 Million EUR | 0.0% |
2011 Q2 | - EUR | 100.0% |
2010 Q1 | -119.52 Million EUR | 0.0% |
2010 Q3 | -119.52 Million EUR | 0.0% |
2010 FY | 478.1 Million EUR | 4.87% |
2010 Q4 | - EUR | 100.0% |
2010 Q2 | - EUR | 100.0% |
2009 FY | 455.9 Million EUR | 12.26% |
2009 Q3 | -113.97 Million EUR | 0.0% |
2009 Q4 | - EUR | 100.0% |
2009 Q1 | -113.97 Million EUR | -173.91% |
2009 Q2 | -113.97 Million EUR | 0.0% |
2008 Q1 | 154.2 Million EUR | 2.78% |
2008 Q4 | 154.2 Million EUR | 0.0% |
2008 Q3 | 154.2 Million EUR | 0.0% |
2008 Q2 | 154.2 Million EUR | 0.0% |
2008 FY | 406.1 Million EUR | 1.83% |
2007 Q1 | 150.02 Million EUR | 48.14% |
2007 Q4 | 150.02 Million EUR | 0.0% |
2007 Q3 | 150.02 Million EUR | 0.0% |
2007 Q2 | 150.02 Million EUR | 0.0% |
2007 FY | 398.8 Million EUR | 1.61% |
2006 Q4 | 101.27 Million EUR | 0.0% |
2006 FY | 392.5 Million EUR | 2.86% |
2006 Q1 | 101.27 Million EUR | 206.16% |
2006 Q2 | 101.27 Million EUR | 0.0% |
2006 Q3 | 101.27 Million EUR | 0.0% |
2005 FY | 381.6 Million EUR | 0.0% |
2005 Q3 | -95.4 Million EUR | 0.0% |
2005 Q2 | -95.4 Million EUR | 0.0% |
2005 Q4 | -95.4 Million EUR | 0.0% |
2005 Q1 | -95.4 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Biosynex SA | 86.53 Million EUR | -1572.83% |
Predilife S.A. | 4.14 Million EUR | -34787.602% |
Eurofins Scientific SE | 73.6 Million EUR | -1866.848% |
Lumibird SA | 115.93 Million EUR | -1148.609% |